Norepinephrine Kabi (Noradrenaline Tartrate)

Norepinephrine, the active ingredient in Norepinephrine Kabi, is a sympathomimetic presented as a sterile solution for injection for intravenous use. It acts as a potent vasopressor and inotropic agent, used to raise blood pressure and improve cardiac output in patients with severe hypotension, septic shock, or cardiac arrest. The product conforms to EU market standards and is manufactured under strict quality controls.

GNH USA supplies Norepinephrine Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Norepinephrine is a sympathomimetic vasopressor used in critical care to support cardiovascular function.

- Hypotension: restores systemic vascular resistance and raises arterial pressure. - Septic shock: improves perfusion pressure and organ blood flow during severe infection‑induced vasodilation. - Cardiac arrest: provides immediate vasoconstriction to facilitate coronary and cerebral perfusion during resuscitation.

Adverse reactions to Norepinephrine may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate headache during infusion. - Tachycardia: increased heart rate from β1 activation. - Nausea: occasional nausea or vomiting.

Serious or Rare Side Effects: - Cardiac arrhythmias: potentially life‑threatening rhythm disturbances. - Severe hypertension: abrupt, excessive rise in blood pressure. - Peripheral ischemia: reduced blood flow that can lead to tissue injury.

When using Norepinephrine, clinicians should observe specific precautions to minimize risks. - Dose titration: adjust infusion rate to achieve target blood pressure while monitoring hemodynamics. - Cardiac monitoring: continuous ECG and arterial pressure monitoring is required. - Extravasation risk: avoid peripheral veins; use central venous access when possible. - Concomitant MAO inhibitors: may potentiate hypertensive response; use with caution. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Norepinephrine may interact with other medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - MAO inhibitors: can cause exaggerated hypertensive response. - Tricyclic antidepressants: synergistic increase in blood pressure. - β‑blockers: may blunt β1‑mediated cardiac effects.

Moderate Interactions (Monitor Closely): - Vasodilators (e.g., nitroglycerin): may reduce pressor effect, requiring dose adjustments. - Calcium channel blockers: can affect vascular tone and heart rate. - Diuretics: may influence intravascular volume and response to norepinephrine.